ReviewFrontiers in immunology2021
Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities.
Xueying Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ReviewFrontiers in immunology2021
Xueying Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.